Pfizer is turning to M&A to get its next blockbuster, buying Biohaven six months after the two companies began a commercialization pact centered on the oral migraine drug Nurtec. The acquisition will lead to the spinout of Biohaven's other assets into a new, publicly traded company capitalized with $275 million.
This event will bring together healthcare futurists, novel employers, payers, providers, and forward-thinking investors and entrepreneurs who support the broad transformation being spearheaded by digital health technologies.
Register by Friday, June 3rd to Save $200* with the Extreme Early Bird Rate
By Michael Schroeder Tuesday, May 10, 2022 2:50 PM
The Series B funding round was led by DFJ Growth. Osmind helps the medical community administer treatments, and track and study the effectiveness of those treatments for 14 million U.S. patients living with moderate and serious mental illness, according to the company.
Companies in every industry are now hiring a chief medical officer—an executive once found only in healthcare organizations—to implement and oversee programs that optimize employee well-being.
In an interview, Teladoc Health CEO Jason Gorevic talked about its services for primary care, chronic conditions, mental health, and how it works with hospitals and health systems.
No comments